SCHEMBL5152157

SCHEMBL5152157

COc1cc(CC(=O)O)ccc1N(C(N)=O)c1ccccc1I

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.48
ALDH1A1 P00352 2/20 0.48
TSHR P16473 1/20 0.48
NFKB1 P19838 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
CA5A P35218 1/20 0.43
LMNA P02545 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C19 P33261 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
SELL P14151 1/20 0.40
SELP P16109 1/20 0.40
KMT2A Q03164 1/20 0.40
BCHE P06276 2/20 0.39
ACHE P22303 2/20 0.39
PTGS1 P23219 1/20 0.39
AKR1C3 P42330 1/20 0.39
AKR1C2 P52895 1/20 0.39
LTB4R Q15722 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5155305 0.87 GAA (0.49) GAAALDH1A1TSHRNFKB1TDP1
SCHEMBL6234919 0.86 GAA (0.48) GAAALDH1A1TSHRNFKB1TDP1
SCHEMBL5155259 0.86 ALDH1A1 (0.48) GAAALDH1A1TSHRNFKB1TDP1
SCHEMBL6962762 0.86 GAA (0.48) GAAALDH1A1TSHRNFKB1TDP1
SCHEMBL5273127 0.85 GAA (0.52) GAAALDH1A1TSHRNFKB1TDP1
SCHEMBL5152274 0.83 GAA (0.45) GAAALDH1A1TSHRNFKB1TDP1
SCHEMBL6964628 0.82 GAA (0.46) GAAALDH1A1TSHRNFKB1TDP1
SCHEMBL17653880 0.74 GAA (0.64) GAAALDH1A1TSHRNFKB1TDP1
SCHEMBL27495785 0.74 PTGER1 (0.41) GAAALDH1A1LMNACYP1A2CYP3A4
SCHEMBL6037550 0.73 MTNR1A (0.50) GAAALDH1A1TDP1LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7179819-B2 VLA-4 inhibitor compounds DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-02-20 US disclosed
US-20040229858-A1 VLA-4 inhibitor compounds DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-18 US disclosed
US-20030078249-A1 VLA-4 inhibitor compounds DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2003-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078249-A1 VLA-4 inhibitor compounds VCAM1, ICAM1, ITGA4 GAA 1709/4885ALDH1A1 146/4885TSHR 3417/4885
US-20040229858-A1 VLA-4 inhibitor compounds VCAM1, ICAM1, ITGB4 GAA 1727/4885ALDH1A1 135/4885TSHR 3192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.